- Home
- JRS vs DRTS Comparison
JRS vs DRTS Comparison
Compare JRS & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRS
- DRTS
- Stock Information
- Founded
- JRS 2001
- DRTS 2015
- Country
- JRS United States
- DRTS Israel
- Employees
- JRS N/A
- DRTS N/A
- Industry
- JRS Finance/Investors Services
- DRTS Medical/Dental Instruments
- Sector
- JRS Finance
- DRTS Health Care
- Exchange
- JRS Nasdaq
- DRTS Nasdaq
- Market Cap
- JRS 224.5M
- DRTS 256.2M
- IPO Year
- JRS N/A
- DRTS N/A
- Fundamental
- Price
- JRS $8.02
- DRTS $3.21
- Analyst Decision
- JRS
- DRTS Strong Buy
- Analyst Count
- JRS 0
- DRTS 1
- Target Price
- JRS N/A
- DRTS $9.00
- AVG Volume (30 Days)
- JRS 86.6K
- DRTS 60.6K
- Earning Date
- JRS 01-01-0001
- DRTS 08-11-2025
- Dividend Yield
- JRS 8.87%
- DRTS N/A
- EPS Growth
- JRS N/A
- DRTS N/A
- EPS
- JRS N/A
- DRTS N/A
- Revenue
- JRS N/A
- DRTS N/A
- Revenue This Year
- JRS N/A
- DRTS N/A
- Revenue Next Year
- JRS N/A
- DRTS N/A
- P/E Ratio
- JRS N/A
- DRTS N/A
- Revenue Growth
- JRS N/A
- DRTS N/A
- 52 Week Low
- JRS $5.95
- DRTS $2.11
- 52 Week High
- JRS $8.00
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- JRS 66.64
- DRTS 52.03
- Support Level
- JRS $7.77
- DRTS $3.03
- Resistance Level
- JRS $7.87
- DRTS $3.58
- Average True Range (ATR)
- JRS 0.10
- DRTS 0.20
- MACD
- JRS 0.04
- DRTS -0.01
- Stochastic Oscillator
- JRS 87.36
- DRTS 38.33
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.